André Veillette

André Veillette is a Full Professor and Researcher in the Department of Medicine at the Université de Montréal, affiliated with the Montreal Clinical Research Institute (IRCM). He holds the Canada Research Chair in Signaling in the Immune System. His research focuses on understanding signaling pathways in the immune and hematopoietic systems, particularly mechanisms regulating T cell activation, NK cell function, and immune checkpoint pathways in cancer. Key contributions include discoveries related to the role of Csk kinase, SAP adaptors, and SLAM family receptors in immune regulation.

• Affiliations: IRCM (Molecular Oncology Research Unit), Université de Montréal, McGill University (Adjunct Professor).
• Educations: MD from Laval University, postdoctoral training at the National Cancer Institute, USA.

Research Interests: Immune signaling, molecular oncology, cancer immunotherapy, autoimmunity, and immunodeficiency. His lab investigates how intracellular molecules like SAP, SLAM receptors, and Csk regulate immune responses and contribute to diseases like leukemia, lymphoma, and autoimmune conditions.

Grants & Projects: Leader of multiple grants from CIHR, Canadian Institutes of Health Research, and international collaborations. Current projects include targeting immune checkpoints like CD47-SIRPα and studying SLAM receptors in anti-cancer immunity.

Awards: 2007 Léo-Pariseau Prize (Acfas), Royal Society of Canada membership (2008), and 2009 Bernhard Cinader Award (Canadian Society for Immunology).

Labs/Teams: Molecular Oncology Research Unit at IRCM, focusing on translational research in immune signaling and cancer therapy.